Recursion Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Recursion Pharmaceuticals

08/08/2024 22:52

* Recursion Pharmaceuticals Inc  RXRX.OQ  reported a
quarterly
adjusted loss of 40 cents​​ per share for the quarter ended in
June, lower than the same quarter last year, when the company
reported EPS of -38 cents.  The mean expectation of
seven analysts for the quarter was for a loss of 40 cents per
share. Wall Street expected results to range from -43 cents
to -35 cents per share.
    * Revenue rose 30.9% to $14.42 million from a year ago;
analysts
expected $13.26 million. 
    * Recursion Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 40 cents​.
    * The company reported a quarterly loss of $97.54 million.
    * Recursion Pharmaceuticals Inc shares had fallen by 15.1%
this
quarter and lost 35.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 3.6%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Recursion
Pharmaceuticals Inc is $11.00 
This summary was machine generated from LSEG data August 8 at
09:51 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.40          -0.40          Met
 Mar. 31 2024      -0.42          -0.39          Beat
 Dec. 31 2023      -0.45          -0.42          Beat
 Sep. 30 2023      -0.38          -0.43          Missed